
$42
0 reviews
Elravie Premier Light-LC – Precision Hyaluronic Acid Filler for Fine Facial Rejuvenation
Product Description
Elravie Premier Light-LC is a premium monophasic dermal filler developed by Humedix Co., Ltd. in South Korea. Utilizing advanced HI (High molecular Ideal Reticulated Matrix) technology, this filler offers high viscosity and elasticity, making it ideal for correcting fine facial wrinkles and enhancing skin hydration. The inclusion of 0.3% lidocaine ensures a more comfortable experience during procedures.
-
Hyaluronic Acid (HA): 23 mg/ml, cross-linked for enhanced stability and longevity.
-
Lidocaine: 0.3% to minimize discomfort during injection.
-
Technology: HI technology ensures a stable gel structure with reduced residual BDDE, decreasing the risk of edema and allergic reactions.
Indications
-
Correction of fine perioral wrinkles, crow’s feet, forehead lines, and glabellar lines.
-
Lip shape and volume correction.
-
Natural-Looking Results: Provides a smooth and natural finish, especially in areas requiring subtle volume enhancement.
-
Long-Lasting Effect: Results can last between 9 to 12 months, depending on individual factors.
-
High Cohesiveness: Ensures the filler maintains its shape and position over time, reducing the risk of migration.
-
Safe and Biocompatible: Made from high-purity, non-animal-derived hyaluronic acid, ensuring compatibility with the body.
Scope of Application
-
Facial Areas: Periorbital lines, tear troughs, glabellar lines, and oral commissures in the lips.
-
Injection Depth: Middle layer of the dermis.
Duration of Effect
The aesthetic effects of Elravie Premier Light-LC typically last between 9 to 12 months. Duration may vary based on individual skin type, lifestyle, and treatment area.
Packaging and Specifications
-
Packaging: 1 pre-filled syringe × 1.0 ml per box.
-
Needle Size: 27G thin-walled needle included for precise application.
-
Storage Conditions: Store at 1°C to 30°C (34°F to 86°F), away from direct sunlight and freezing temperatures.
-
Manufacturer: Humedix Co., Ltd., South Korea.